Clinical Trial Update: Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating cytotoxic T lymphocyte therapy for post-transplant lymphoproliferative disorder after liver transplantation; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoproliferative Disorders
• Post-transplant Lymphoproliferative Disorder

Drugs mentioned

• Cytotoxic T lymphocytes therapy (cytotoxic T lymphocytes)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Liver Disease, Lymphoproliferative Disorders | Phase 1 | Status: COMPLETED